Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
STAR Protocols|August 30, 2025
Serial viral passage and reverse genetics protocol for identifying the antiviral drug targets of EV-D68 antiviralsHaozhou Tan, Kan Li, Jun Wang
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|May 17, 2022
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitorHaozhou Tan, Chunlong Ma, Jun Wang
Research Square|April 5, 2022
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitorHaozhou Tan, Chunlong Ma, Jun Wang
STAR Protocols|June 17, 2023
FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLproHaozhou Tan, Yanmei Hu, Jun Wang
ACS Pharmacology & Translational Science|February 19, 2026
Characterization of the Cross-Resistance of SARS-CoV‑2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and NirmatrelvirHaozhou Tan, Xiang Chi, Xufang Deng, et al.
ACS Infectious Diseases|November 23, 2024
Discovery of A-967079 as an Enterovirus D68 Antiviral by Targeting the Viral 2C ProteinHaozhou Tan, Brian Pollard, Kan Li, et al.
Briefings in Functional Genomics|June 15, 2026
Genetically supported mediators linking peripheral metabolism to cerebral ischemia: a multi-omics characterization of HMGCR, TLR4, and MMP9 in angina pectoris and strokeYing Li, Haozhou Tan, Li Zhao, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like ProteaseKan Li, Prakash Jadhav, Yu Wen, et al.
Journal of Medicinal Chemistry|May 27, 2022
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like ProteaseHaozhou Tan, Yanmei Hu, Prakash Jadhav, et al.
Acta Pharmaceutica Sinica. B|November 8, 2021
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assaysChunlong Ma, Haozhou Tan, Juliana Choza, et al.
Pageof 5